Protalix BioTherapeutics, Inc. (19) | Uncategorized (3)
- Letter Amendment dated May 2, 2022 (Filed With SEC on May 2, 2022)
- At the Market Offering Agreement, dated July 2, 2021, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on July 2, 2021)
- Amended and Restated Agreement between Protalix Ltd. and Comercio e Servios Ltda. dated June 17, 2013 (Filed With SEC on May 14, 2021)
